Literature DB >> 15721253

Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1.

Yong Li1, Mihwa Choi, Greg Cavey, Jennifer Daugherty, Kelly Suino, Amanda Kovach, Nathan C Bingham, Steven A Kliewer, H Eric Xu.   

Abstract

The orphan nuclear receptor steroidogenic factor 1 (SF-1) regulates the differentiation and function of endocrine glands. Although SF-1 is constitutively active in cell-based assays, it is not known whether this transcriptional activity is modulated by ligands. Here, we describe the 1.5 angstroms crystal structure of the SF-1 ligand binding domain in complex with an LXXLL motif from a coregulator protein. The structure reveals the presence of a phospholipid ligand in a surprisingly large pocket (approximately 1600 angstroms3), with the receptor adopting the canonical active conformation. The bound phospholipid is readily exchanged and modulates SF-1 interactions with coactivators. Mutations designed to reduce the size of the SF-1 pocket or to disrupt hydrogen bonds with the phospholipid abolish SF-1/coactivator interactions and significantly reduce SF-1 transcriptional activity. These findings provide evidence that SF-1 is regulated by endogenous ligands and suggest an unexpected relationship between phospholipids and endocrine development and function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721253     DOI: 10.1016/j.molcel.2005.02.002

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  98 in total

1.  Time to face the fats: what can mass spectrometry reveal about the structure of lipids and their interactions with proteins?

Authors:  Simon H J Brown; Todd W Mitchell; Aaron J Oakley; Huong T Pham; Stephen J Blanksby
Journal:  J Am Soc Mass Spectrom       Date:  2012-06-06       Impact factor: 3.109

Review 2.  Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.

Authors:  Thomas P Burris; Scott A Busby; Patrick R Griffin
Journal:  Chem Biol       Date:  2012-01-27

3.  Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation.

Authors:  Paul M Musille; Manish Pathak; Janelle L Lauer; William H Hudson; Patrick R Griffin; Eric A Ortlund
Journal:  Nat Struct Mol Biol       Date:  2012-04-15       Impact factor: 15.369

Review 4.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

5.  Challenges in studying phospholipid signaling.

Authors:  Carsten Schultz
Journal:  Nat Chem Biol       Date:  2010-07       Impact factor: 15.040

6.  The orphan nuclear receptor TR4 is a vitamin A-activated nuclear receptor.

Authors:  X Edward Zhou; Kelly M Suino-Powell; Yong Xu; Cee-Wah Chan; Osamu Tanabe; Schoen W Kruse; Ross Reynolds; James Douglas Engel; H Eric Xu
Journal:  J Biol Chem       Date:  2010-11-09       Impact factor: 5.157

Review 7.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

Review 8.  Endogenous ligands for nuclear receptors: digging deeper.

Authors:  Michael Schupp; Mitchell A Lazar
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

9.  E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis.

Authors:  Anna Ehrlund; Elin Holter Anthonisen; Nina Gustafsson; Nicolas Venteclef; Kirsten Robertson Remen; Anastasios E Damdimopoulos; Anastasia Galeeva; Markku Pelto-Huikko; Enzo Lalli; Knut R Steffensen; Jan-Ake Gustafsson; Eckardt Treuter
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

10.  Solution Nuclear Magnetic Resonance Studies of the Ligand-Binding Domain of an Orphan Nuclear Receptor Reveal a Dynamic Helix in the Ligand-Binding Pocket.

Authors:  Nicolas Daffern; Zhonglei Chen; Yongbo Zhang; Leslie Pick; Ishwar Radhakrishnan
Journal:  Biochemistry       Date:  2018-03-22       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.